Quick Answer
ASPEN AEROGELS INC reported R&D Expense of $13.42 million for fiscal year 2025.
ASPEN AEROGELS INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $13.42M | -25.7% |
| 2024 | $18.05M | +10.4% |
| 2023 | $16.36M | -3.4% |
| 2022 | $16.93M | +48.0% |
| 2021 | $11.44M | +31.1% |
| 2020 | $8.73M | +3.8% |
| 2019 | $8.41M | +33.0% |
| 2018 | $6.32M | +2.2% |
| 2017 | $6.18M | +16.5% |
| 2016 | $5.31M | +1.0% |
| 2015 | $5.25M | -12.2% |
| 2014 | $5.98M | +15.9% |
| 2013 | $5.16M | +0.3% |
| 2012 | $5.14M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.49M | -45.7% | -34.3% |
| June 30, 2025 | $3.79M | -16.9% | -12.4% |
| March 31, 2025 | $4.33M | -3.5% | -5.6% |
| September 30, 2024 | $4.59M | +8.8% | +0.6% |
| June 30, 2024 | $4.57M | +15.2% | +1.7% |
| March 31, 2024 | $4.49M | +9.5% | +6.4% |
| September 30, 2023 | $4.22M | -10.1% | +6.4% |
| June 30, 2023 | $3.96M | -10.9% | -3.3% |
- ASPEN AEROGELS INC showed a decrease of -25.7% in R&D Expense compared to the prior fiscal year.
- Over the 2012–2025 period, ASPEN AEROGELS INC’s r&d expense has grown by 160.9% (from $5.14 million to $13.42 million).
- The most recent figure is from ASPEN AEROGELS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: